IL31 and osteoporosis: The deepening of the knowledge of the roles of IL-31 and IL-33 in the immunoskeletal interface can contribute to better understanding of those mechanisms underlying the functioning of the immune system that trigger osteoclastogenic inflammatory reactions, crucial in osteoporosis.